Related Experiment Video
Updated: Nov 24, 2025
09:04
Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells
Published on: March 7, 2025
1.0K
Tumor-driven evolution of immunosuppressive networks during malignant progression
Ryungsa Kim1, Manabu Emi, Kazuaki Tanabe
1International Radiation Information Center, Research Institute for Radiation Biology and Medicine, Hiroshima University, Japan. rkim@hiroshima-u.ac.jp
Cancer Research
|June 3, 2006
Summary
Tumors develop immunosuppressive networks using secreted factors to evade immune detection. These factors promote cancer progression and metastasis by suppressing anti-tumor immune responses locally and systemically.
Area of Science:
- Immunology
- Oncology
- Cancer Biology
Background:
- Tumors employ immune evasion strategies, including immune editing, which can drive malignant progression.
- The tumor microenvironment is shaped by immunosuppressive networks that hinder anti-tumor immunity.
Purpose of the Study:
- To elucidate the mechanisms by which tumor-derived factors create immunosuppressive networks.
- To understand how these networks contribute to immune evasion and cancer progression.
Main Methods:
- Review and synthesis of existing literature on tumor-derived immunosuppressive factors.
- Analysis of the roles of specific factors like VEGF, IL-10, TGF-β, and soluble proteins.
Main Results:
- Tumor-derived factors, including vascular endothelial growth factor (VEGF), recruit immunosuppressive cells like myeloid-derived suppressor cells and macrophages.
- Secreted factors create immunosuppressive networks in the tumor microenvironment, lymph nodes, and spleen.
- Specific factors like soluble Fas and MHC class I-related chain A proteins aid tumor cells in escaping cytotoxic T cell and NK cell-mediated killing.
Conclusions:
- Tumor-derived factors orchestrate a complex immunosuppressive network that promotes immune evasion.
- This network extends beyond the primary tumor site, facilitating invasion, metastasis, and overall cancer progression.
Related Concept Videos
01:27Tumor Immunotherapy
877
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
877
02:07Tumor Progression
6.9K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.9K
02:17The Tumor Microenvironment
7.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.3K
03:03mTOR Signaling and Cancer Progression
4.1K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.1K
02:53Adaptive Mechanisms in Cancer Cells
6.2K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.2K
02:23Abnormal Proliferation
4.9K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.9K